| pubmed-article:19573950 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19573950 | lifeskim:mentions | umls-concept:C0599755 | lld:lifeskim |
| pubmed-article:19573950 | lifeskim:mentions | umls-concept:C0030567 | lld:lifeskim |
| pubmed-article:19573950 | lifeskim:mentions | umls-concept:C1446659 | lld:lifeskim |
| pubmed-article:19573950 | lifeskim:mentions | umls-concept:C0018591 | lld:lifeskim |
| pubmed-article:19573950 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:19573950 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19573950 | pubmed:dateCreated | 2011-3-28 | lld:pubmed |
| pubmed-article:19573950 | pubmed:abstractText | To determine whether polymorphisms in the microtubule-associated protein tau (MAPT) and/or glycogen synthase kinase-3? (GSK3?) genes underpin susceptibility to Parkinson's disease (PD), we conducted a case-control association study in a Greek cohort of 196 PD cases and 163 healthy controls. In our study, the MAPT H1 haplotype was found to be significantly associated with PD, no association was detected between the intronic rs6438552 (-157 T/C) GSK3? polymorphism and PD, whereas the C/C genotype of the promoter rs334558 (-50 T/C) GSK3? polymorphism was found to exert a protective role. The C/C genotype of the rs334558 GSK3? polymorphism was also found to have an additional protective role in our MAPT H1/H1 PD subgroup. Haplotype analysis revealed that, the T-T haplotype of both GSK3? polymorphisms was over-represented in PD patients compared to controls, and this association was independent of MAPT H1 haplotype. | lld:pubmed |
| pubmed-article:19573950 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19573950 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19573950 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19573950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19573950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19573950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19573950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19573950 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19573950 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:19573950 | pubmed:issn | 1558-1497 | lld:pubmed |
| pubmed-article:19573950 | pubmed:author | pubmed-author:KotsisAlexand... | lld:pubmed |
| pubmed-article:19573950 | pubmed:author | pubmed-author:FidaniLianaL | lld:pubmed |
| pubmed-article:19573950 | pubmed:author | pubmed-author:Bostantjopoul... | lld:pubmed |
| pubmed-article:19573950 | pubmed:author | pubmed-author:KatsarouZoeZ | lld:pubmed |
| pubmed-article:19573950 | pubmed:author | pubmed-author:ClarimónJordi... | lld:pubmed |
| pubmed-article:19573950 | pubmed:author | pubmed-author:KalinderiKall... | lld:pubmed |
| pubmed-article:19573950 | pubmed:copyrightInfo | Copyright © 2009 Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:19573950 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19573950 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:19573950 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19573950 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19573950 | pubmed:pagination | 546.e1-5 | lld:pubmed |
| pubmed-article:19573950 | pubmed:dateRevised | 2011-11-2 | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:meshHeading | pubmed-meshheading:19573950... | lld:pubmed |
| pubmed-article:19573950 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:19573950 | pubmed:articleTitle | GSK3? polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort. | lld:pubmed |
| pubmed-article:19573950 | pubmed:affiliation | Department of General Biology, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. | lld:pubmed |
| pubmed-article:19573950 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19573950 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:2932 | entrezgene:pubmed | pubmed-article:19573950 | lld:entrezgene |
| entrez-gene:4137 | entrezgene:pubmed | pubmed-article:19573950 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19573950 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19573950 | lld:entrezgene |
